DGAP-News: Fresenius Medical Care AG & Co. KGaA: Standard & Poor's upgrades Fresenius Medical Care's credit rating to investment grade

Fresenius Medical Care AG & Co. KGaA: Standard & Poor's upgrades Fresenius Medical Care's credit rating to investment grade

DGAP-News: Fresenius Medical Care AG & Co. KGaA / Schlagwort(e):

Sonstiges

Fresenius Medical Care AG & Co. KGaA: Standard & Poor's upgrades

Fresenius Medical Care's credit rating to investment grade

19.01.2015 / 18:32

---------------------------------------------------------------------

Standard & Poor's upgrades Fresenius Medical Care's credit rating to

investment grade

Bad Homburg, Germany - Fresenius Medical Care AG & Co. KGaA (the "company"

or "Fresenius Medical Care"; Frankfurt Stock Exchange: FME / New York Stock

Exchange: FMS), the world's largest provider of dialysis products and

services, today announced that Standard & Poor's has upgraded the corporate

credit rating of Fresenius Medical Care from BB+ to BBB- with a stable

outlook. The company's financial policy remains unchanged. Fresenius

Medical Care will continue to focus on the execution of the long-term

strategy introduced in early 2014.

About Fresenius Medical Care

Fresenius Medical Care is the world's largest integrated provider of

products and services for individuals undergoing dialysis because of

chronic kidney failure, a condition that affects more than 2.5 million

individuals worldwide. Through its network of 3,349 dialysis clinics in

North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius

Medical Care provides dialysis treatments for 283,135 patients around the

globe. Fresenius Medical Care is also the world's leading provider of

dialysis products such as hemodialysis machines, dialyzers and related

disposable products.

For more information about Fresenius Medical Care, visit the company's

website at www.fmc-ag.com.

Disclaimer

This release contains forward-looking statements that are subject to

various risks and uncertainties. Actual results could differ materially

from those described in these forward-looking statements due to certain

factors, including changes in business, economic and competitive

conditions, regulatory reforms, foreign exchange rate fluctuations,

uncertainties in litigation or investigative proceedings, and the

availability of financing. These and other risks and uncertainties are

detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the

U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co.

KGaA does not undertake any responsibility to update the forward-looking

statements in this release.

---------------------------------------------------------------------

19.01.2015 Veröffentlichung einer Corporate News/Finanznachricht,

übermittelt durch DGAP - ein Service der EQS Group AG.

Für den Inhalt der Mitteilung ist der Emittent / Herausgeber

verantwortlich.

Die DGAP Distributionsservices umfassen gesetzliche Meldepflichten,

Corporate News/Finanznachrichten und Pressemitteilungen.

Medienarchiv unter http://www.dgap-medientreff.de und

http://www.dgap.de

---------------------------------------------------------------------

Sprache: Deutsch

Unternehmen: Fresenius Medical Care AG & Co. KGaA

Else-Kröner-Straße 1

61352 Bad Homburg

Deutschland

Telefon: +49 (0) 6172- 609 2525

Fax: +49 (0) 6172- 609 2301

E-Mail: ir@fmc-ag.com

Internet: www.fmc-ag.de

ISIN: DE0005785802, DE0005785836,

WKN: 578580, 578583

Indizes: DAX

Börsen: Regulierter Markt in Frankfurt (Prime Standard);

Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover,

München, Stuttgart; Terminbörse EUREX; NYSE

Ende der Mitteilung DGAP News-Service

---------------------------------------------------------------------

314679 19.01.2015